First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - CRESTMILL PHARMA CONSULTANCY LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: CRESTMILL PHARMA CONSULTANCY LIMITED, RICHFIELDS, SUITE 3 CONGRESS HOUSE, 14 LYON ROAD, HARROW, MIDDLESEX, HA1 2EN. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 19 December 2012.

The accounts next due date is 30 September 2024. There are no mortgages.

The above was based on public record information as at 29 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 08336666
Date Incorporated: 19 December 2012
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 08336666
Annual Return: 19 December 2015
Registered Office: RICHFIELDS, SUITE 3 CONGRESS HOUSE, 14 LYON ROAD, HARROW, MIDDLESEX, HA1 2EN
SIC Code and Operations: 70229
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CRESTMILL PHARMA CONSULTANCY LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 8 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
LP016991 CRESTMILL SALES L.P. Active
11847363 CRESTML LIMITED Active
12791439 CRESTMONDS LTD Active
08870453 CRESTMONT LTD Active - Proposal to Strike off
10864240 CRESTMONTE CONSULTING LTD. Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd